Target intelligence / Profile preview

Guanylate cyclase C (GC-C) (GC-C)

Target
GC-C
Molecular classification
Receptor, Enzyme, Guanylate cyclase, Particulate guanylate cyclase
01

Overview

Guanylate cyclase C (GC-C) is a transmembrane receptor and enzyme primarily expressed on the apical membrane of intestinal epithelial cells (UniProt P25092). It serves as the physiological receptor for the endogenous peptides guanylin and uroguanylin, and it is the primary target for the bacterial heat-stable enterotoxin (STa) produced by enterotoxigenic Escherichia coli (ETEC) (PubMed: 2010 review, PMC: Cure and Curse). Activation of GC-C by these ligands triggers the synthesis of cyclic GMP (cGMP), which acts as a second messenger to regulate ion transport and fluid homeostasis in the gut (ResearchGate: Mechanism of action). In ETEC infections, the overactivation of GC-C by STa leads to profuse secretory diarrhea (PMC: Heat-stable enterotoxins and immunity). Conversely, synthetic agonists of GC-C, such as linaclotide and plecanatide, are therapeutically utilized to treat chronic idiopathic constipation and constipation-predominant irritable bowel syndrome (IBS-C) by promoting intestinal secretion and transit (PubMed: 2010 review). Beyond its role in fluid regulation, GC-C is also investigated as a biomarker and therapeutic target in colorectal cancer, where its expression is maintained in metastatic cells (MDPI: GC-C as a Pharmacological Target). Additionally, the heat-stable enterotoxin itself is a target for vaccine development aimed at preventing ETEC-mediated diarrheal disease (PMC: ST as a Vaccine Target).

Other names
Heat-stable enterotoxin receptorGuanylyl cyclase CGUCY2CSTARGUC2ChSTARIntestinal guanylate cyclaseSTa receptorHeat-stable enterotoxin
02

Mechanism of action

Agonism of the receptor leads to increased intracellular cyclic GMP (cGMP), which activates protein kinase G II (PKG-II) and inhibits phosphodiesterase 3 (PDE3). This results in the activation of the cystic fibrosis transmembrane conductance regulator (CFTR) and inhibition of the sodium-hydrogen exchanger 3 (NHE3), promoting the secretion of chloride and bicarbonate and inhibiting sodium absorption, which collectively drive fluid secretion into the intestinal lumen.

03

Biological functions

Signal transductioncGMP biosynthesisElectrolyte homeostasisFluid secretionCell proliferationApoptosis
04

Disease associations

InfectionIrritable bowel syndromeChronic constipationColorectal cancer
05

Safety considerations

DiarrheaDehydrationPediatric safety (Boxed Warning for Linaclotide)
06

Interacting drugs

Linaclotide

3 more in the full profile.

07

Biomarkers

GUCY2C expressionIntracellular cGMP levels

Beyond the preview

Go deeper on Guanylate cyclase C (GC-C) (GC-C).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanylate cyclase C (GC-C) (GC-C).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call